Lindbrook Capital’s Otonomy, Inc. OTIC Stock Holding History

Lindbrook Capital’s Portfolio OTIC Stock Details OTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,000	Closed	-$19K	–	1964
2020 Q4	$19K	Buy	+3,000	New	+$13.6K	﹤0.01%	708

Other funds holding OTIC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Lindbrook Capital's OTIC Position: Q1 2021 in Review

Lindbrook Capital sold out of Otonomy, Inc. (OTIC) in Q1 2021, closing a stake of 3,000 shares — an estimated $19K sold.

Lindbrook Capital first reported a position in OTIC in Q4 2020 and held it in 1 quarter. The position peaked at $19K in Q4 2020. 62 funds tracked by Wall St. Rank hold OTIC as of Q1 2021.

Lindbrook Capital reported no remaining Otonomy, Inc. position as of Q1 2021 after selling out during the quarter.
Lindbrook Capital sold 3,000 Otonomy, Inc. shares in Q1 2021, an estimated $19K.
Lindbrook Capital first reported a position in Otonomy, Inc. in Q4 2020 and held it in 1 quarter.
Lindbrook Capital's Otonomy, Inc. position peaked at $19K in Q4 2020.
62 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q1 2021.

Based on Lindbrook Capital's 13F filing for Q1 2021, filed 28 Apr 2021.